The new tests that detect deadly lung cancer early
aldo crusher for reader's digest international edition Early diagnosis is one of the best ways to beat cancer and there is good news on this front. Two new tests for lung cancer can detect this killer in time for treatment to be effective, thus giving patients a better chance for a cure. In the first test, developed by Vadim Backman, professor of Biomedical Engineering at Northwestern University, Illinois USA, cell samples taken from inside an individual’s cheek are viewed through a specialized microscope. The microscope detects particular cellular changes, indicating whether lung cancer may be developing. The second is a simple breath test! Exhaled breath contains thousands of volatile organic compounds (VOCs) that vary in composition and pattern. A subset of four VOCs have been discovered in the exhaled breath of lung cancer patients. Cambridge, England-based Owlstone Medical developed a microchip sensor technology to measure VOCs in exhaled breath. This type of technology already exists. Co-founder and president of Owlstone Medical, Billy Boyle, says their smaller and less expensive device may become an in-office tool for doctors. “We hope that breath analysis will allow us to diagnose patients with primary or recurrent lung cancer long before they suffer from symptoms, when we have more options for treating them, giving them the best chance for cure,” says cardiothoracic surgeon, Erin M. Schumer, MD, MPH, whose research on this technique was published in early 2016 in The Annals of Thoracic Surgery. (These are lung cancer symptoms you should never ignore.)
The smell test that could detect prostate cancer
aldo crusher for reader's digest international edition A “smell” test promises to be an immediate and accurate diagnostic tool for prostate cancer. This may save thousands of lives and save thousands of men from having to undergo invasive investigations. The test is now in advanced clinical trials and is expected to be available to in late 2017. Dr. Raj Persad, Consultant Urologist at Southmead Hospital, England, said: “If this test succeeds a full medical trial it will revolutionize diagnostics. Even with detailed biopsies there is a risk we may fail to detect prostate cancer in some cases.” More than 1.1 million cases of prostate cancer were recorded globally in 2012, according to the World Cancer Research Fund International. These surprising habits can raise your prostate cancer risk.